Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
442.00    -1.00 (-0.23%)
Bid:
435.00
Ask:
443.00
Spread: 8.00 (1.839%)
Market Cap: £218.23m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

17 Jun 2013 07:58

RNS Number : 1560H
City of London Investment Group PLC
17 June 2013
 



City of London Investment Group PLC

17 June 2013

CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

TRADING UPDATE

for the Year to 31 May 2013

City of London (LSE: CLIG), a leading emerging markets asset management group, provides a trading update for its financial year ended 31 May 2013. The numbers that follow are all unaudited.

Funds under management were US$3.7 billion (£2.4 billion) at 31 May 2013 (2012: US$4.5 billion or £2.9 billion), representing a 17% decrease in US$ terms and a 16% decrease in sterling terms. Over the same period (31 May 2012 to 31 May 2013) the MSCI Emerging Markets Index (MXEF) increased by 11% in US$ terms.

For the year to 31 May 2013, City of London expects that pre-tax profits will be approximately £8.9 million (2012: £11.5 million), and that profits after an anticipated tax charge of £2.6 million (29% of pre-tax profits) will be approximately £6.3 million (2012: profits of £8.5 million after a tax charge of £3.0 million, representing 26% of pre-tax profit). Basic and fully diluted earnings per share are expected to be 24.9p and 24.6p respectively (2012: 33.8p and 32.8p). The above pre-tax figures are stated net of a compromise settlement of £700,000 agreed with two former executives.

The Group has established a dividend policy of 1.5 times earnings cover which is applied with flexibility. As a result of both falls in Emerging Markets, and client redemptions during the first half of the financial year, earnings cover will be reduced this year but given the Group's strong cash position and optimism with regard to the future, the Board is recommending a final dividend of 16p per share (2012: 16p). This would bring the total for the year to 24p (2012: 24p), making cover 1.04 times earnings per share (2012: 1.41 times).

As reported in our half year results, released 21 January 2013, we continue to focus on reducing costs and this has been achieved, resulting in an annualised saving of £1 million.

Investment performance of the Emerging Markets Closed End Fund Strategy has improved very significantly. As noted in last year's Trading Update, the momentum of corporate activity, coupled with mean reversion of net asset value performance and increasing discount volatility have been the major drivers of improved investment performance. With the size weighted average discount of emerging market closed end funds still quite wide, there continue to be trading opportunities to generate further outperformance. We are maintaining a robust pipeline of client additions.

Diversification efforts continue to focus on the Developed closed end fund strategy and the Frontier Emerging Markets Strategy, where both products continue to attract attention from consultants and institutional prospects.

The China A Share Strategy received a mandate for $25 million in December 2012 which closed the Qualified Foreign Institutional Investor account quota of $100 million approved for City of London Investment Management Company Limited (CLIM). A new application for an additional $100 million in QFII quota was requested from the China Securities Regulatory Commission in April 2013 and, if approved, will allow for new marketing opportunities.

City of London Investment Group expects to announce final full year results for the year to 31 May 2013 on 9 September 2013, followed by an Investor Day on 10 September. The Company's Annual General Meeting date and final dividend payment dates are expected to be 7 October 2013 and 25 October 2013 respectively.

Summary and unaudited trading update

Year to 31 May

2013

2012

Funds under Management (at period end)

US$3.7bn

US$4.5bn

Turnover (plus investment income)

£29.9m

£34.6m

Administrative expenses, commission payable, and profit-share

£21.0m

£23.1m

Profit before tax

£8.9m

£11.5m

Profit after tax

£6.3m

£8.5m

Profit per share, basic

24.9p

33.8p

Profit per share, diluted

24.6p

32.8p

 

Financials - consolidated income statement

Year to 31 May

£'000

2013

2012

Fee income

29,363

34,142

Interest & other

501

428

Finder's commission

(4,194)

(5,195)

Custody & Administration

(1,244)

(1,433)

Total net income

24,426

27,942

Costs:

Human resources

7,629

6,765

Premises

612

628

Communications & IT

1,534

1,619

Business development

695

909

General

1,041

1,135

Total costs

11,511

11,056

Operating profit

12,915

16,886

Profit-share

4,055

5,424

Pre-tax profit

8,860

11,462

Tax

(2,594)

(2,964)

Post-tax profit

6,266

8,498

Dividends (prior year final plus current year interim)

(6,046)

(6,052)

Retained

220

2,446

 

 

 

For further information, please visit www.citlon.co.uk or contact:

 

Barry Olliff (Chief Executive)

City of London Investment Group PLC

Tel: +44 (0)20 7711 0771 

 

Martin R Green

Canaccord Genuity Limited

Financial Adviser & Broker

Tel: +44 (0)20 7523 8000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFDSMWFDSEIM
Date   Source Headline
28th Sep 20174:30 pmRNSHolding(s) in Company
22nd Sep 201711:08 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
27th Jan 20164:40 pmRNSSecond Price Monitoring Extn
27th Jan 20164:35 pmRNSPrice Monitoring Extension
13th Jan 20169:57 amRNSHardman Issues Research Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.